This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Trakarnsanga A, Ithimakin S, Weiser MR. Treatment of locally advanced rectal cancer: controversies and questions. World J Gastroenterol 2012; 18: 5521-32. 10.3748/wjg.v18.i39.552123112544TrakarnsangaAIthimakinSWeiserMR.Treatment of locally advanced rectal cancer: controversies and questionsWorld J Gastroenterol20121855213210.3748/wjg.v18.i39.5521Open DOISearch in Google Scholar
Ferrari L, Fichera A Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer. Gastroenterology Report 2015; 3: 277-88. 10.1093/gastro/gov03926290512FerrariLFichera A Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancerGastroenterology Report201532778810.1093/gastro/gov039Open DOISearch in Google Scholar
Peeters KC, van de Velde CJH, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients – a Dutch colorectal cancer group study. J Clin Oncol 2005; 23: 6199-206. 10.1200/JCO.2005.14.77916135487PeetersKCvan de VeldeCJHLeerJWMartijnHJunggeburtJMKranenbargEKLate side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients – a Dutch colorectal cancer group studyJ Clin Oncol200523619920610.1200/JCO.2005.14.779Open DOISearch in Google Scholar
Guillem JG, Chessin DB, Cohen AM, Shia J, Mazumdar M, Enker W, et al. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. AnnSurg 2005; 241: 829-36. 10.1097/01.sla.0000161980.46459.9615849519GuillemJGChessinDBCohenAMShiaJMazumdarMEnkerWLong-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancerAnn Surg20052418293610.1097/01.sla.0000161980.46459.96Open DOISearch in Google Scholar
García-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46: 298-304. 10.1097/01.DCR.0000054637.75996.DF12626903García-AguilarJHernandez de AndaESirivongsP.LeeSHMadoffRDRothenbergerDA.A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excisionDis Colon Rectum20034629830410.1097/01.DCR.0000054637.75996.DFOpen DOISearch in Google Scholar
Hughes R, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, et al. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis 2006; 21: 11-7. https://doi.org/10.1007/s00384-005-0749-y1586460510.1007/s00384-005-0749-yHughesRGlynne-JonesRGraingerJRichmanPMakrisAHarrisonMCan pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?Int J Colorectal Dis200621117https://doi.org/10.1007/s00384-005-0749-ySearch in Google Scholar
Huebner M, Wolff BG, Smyrk TC, Aakre J, Larson DW. Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy. World J Surg 2012; 36: 675-83. 10.1007/s00268-011-1409-822270980HuebnerMWolffBGSmyrkTCAakreJLarsonDW.Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapyWorld J Surg2012366758310.1007/s00268-011-1409-8Open DOISearch in Google Scholar
Kalady MF, de Campos-Lobato LF, Stocchi L, Geisler DP, Dietz D, Lavery IC, et al. Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 2009; 250: 582-9. 10.1097/SLA.0b013e3181b91e6319710605KaladyMFde Campos-LobatoLFStocchiLGeislerDPDietzDLaveryICPredictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancerAnn Surg2009250582910.1097/SLA.0b013e3181b91e63Open DOISearch in Google Scholar
Huh JW, Kim HR, Kim YJ. Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer. Dis Colon Rectum 2013; 56: 698-703. 10.1097/DCR.0b013e3182837e5b23652742HuhJWKimHRKimYJ.Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancerDis Colon Rectum20135669870310.1097/DCR.0b013e3182837e5bOpen DOISearch in Google Scholar
Hermanek P, Merkel S, Hohenberger W. Prognosis of rectal carcinoma after multimodal treatment: ypTNM classification and tumor regression grading are essential. Anticancer Res 2013; 33: 559-66. 10.4143/crt.2015.25423393349HermanekPMerkelSHohenbergerW.Prognosis of rectal carcinoma after multimodal treatment: ypTNM classification and tumor regression grading are essentialAnticancer Res2013335596610.4143/crt.2015.254Open DOISearch in Google Scholar
Kawai K, Ishihara S, Nozawa H, Hata K, Kiyomatsu T, Morikawa T, et al. Prediction of pathological complete response using endoscopic findings and outcomes of patients who underwent watchful waiting after chemoradiotherapy for rectal cancer. Dis Colon Rectum 2017; 60: 368–375. 10.1097/DCR.000000000000074228267003KawaiKIshiharaSNozawaHHataKKiyomatsuTMorikawaTPrediction of pathological complete response using endoscopic findings and outcomes of patients who underwent watchful waiting after chemoradiotherapy for rectal cancerDis Colon Rectum20176036837510.1097/DCR.0000000000000742Open DOISearch in Google Scholar
Smith FM, Wiland H, Mace A, Pai RK, Kalady MF. Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum 2014; 57: 311–315. 10.1097/DCR.0b013e3182a84eba24509452SmithFMWilandHMaceAPaiRKKaladyMF.Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapyDis Colon Rectum20145731131510.1097/DCR.0b013e3182a84ebaOpen DOISearch in Google Scholar
Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 7th edition. New York: John Wiley & Sons; 2009.SobinLHGospodarowiczMKWittekindC.TNM classification of malignant tumours7thNew YorkJohn Wiley & Sons200910.1002/9780471420194.tnmc26.pub2Search in Google Scholar
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorect Dis 1997; 12: 19-23.10.1007/s003840050072DworakOKeilholzLHoffmannA.Pathological features of rectal cancer after preoperative radiochemotherapyInt J Colorect Dis1997121923Open DOISearch in Google Scholar
Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 2012; 99: 918-28. 10.1002/bjs.870222362002MartinSTHeneghanHMWinterDC.Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancerBr J Surg2012999182810.1002/bjs.8702Open DOISearch in Google Scholar
Fraser MS, Rao C, Perez RO, Bujko K, Habr-Gama A, Faiz O. Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic mode. Dis Colon Rectum 2015; 58: 159-171.10.1097/DCR.0000000000000281FraserMSRaoCPerezROBujkoKHabr-GamaAFaizO.Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic modeDis Colon Rectum201558159171Open DOISearch in Google Scholar
Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 2007; 14: 2766-72. 10.1245/s10434-007-9471-z17551794KuoLJLiuMCJianJJHorngCFChengTIChenCMIs final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?Ann Surg Oncol20071427667210.1245/s10434-007-9471-zOpen DOISearch in Google Scholar
Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45: 895-903. org/10.1007/s10350-004-6325-712130878TheodoropoulosGWiseWEPadmanabhanAKernerBATaylorCWAguilarPST-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survivalDis Colon Rectum200245895903org/10.1007/s10350-004-6325-7Open DOISearch in Google Scholar
Sprenger T, Rothe H, Conradi CR, Beissbarth T, Kauffels A, Kitz J, et al. Stage-dependent frequency of lymph node metastases in patients with rectal carcinoma after preoperative chemoradiation: results from the CAO/ARO/AIO-94 trial and from a comparative prospective evaluation with extensive pathological workup. Dis Colon Rectum 2016; 59: 377-385. 10.1097/DCR.0000000000000570SprengerTRotheHConradiCRBeissbarthTKauffelsAKitzJStage-dependent frequency of lymph node metastases in patients with rectal carcinoma after preoperative chemoradiation: results from the CAO/ARO/AIO-94 trial and from a comparative prospective evaluation with extensive pathological workupDis Colon Rectum20165937738510.1097/DCR.0000000000000570Open DOISearch in Google Scholar
Kong JC, Guerra RG, Warrier SK, Ramsay RG, Heriot AG. Outcome and salvage surgery following “Watch and Wait” for rectal cancer after neoadjuvant therapy: a systematic review. Dis Colon Rectum 2017; 60: 335-345. 10.1097/DCR.000000000000075428177997KongJCGuerraRGWarrierSKRamsayRGHeriotAG.Outcome and salvage surgery following “Watch and Wait” for rectal cancer after neoadjuvant therapy: a systematic reviewDis Colon Rectum20176033534510.1097/DCR.0000000000000754Open DOISearch in Google Scholar
Kim NK, Kim MS, Al-Asari SF. Update and debate issues in surgical treatment of middle and low rectal cancer. J Korean Soc Coloproctol 2012; 28: 230-240. 10.1097/SLA.0b013e31829068c523185702KimNKKimMSAl-AsariSF.Update and debate issues in surgical treatment of middle and low rectal cancerJ Korean Soc Coloproctol20122823024010.1097/SLA.0b013e31829068c5Open DOISearch in Google Scholar
Maas M, Beets-Tan RG, Lanbregts DM, Lammering G, Nelemans PJ, Engelen SM, et al. Wait-and-see policy for clinical complete responders after chemoradioation for rectal cancer. J Clin Oncol 2011; 29: 4633-40. 10.1200/JCO.2011.3722067400MaasMBeets-TanRGLanbregtsDMLammeringGNelemansPJEngelenSMWait-and-see policy for clinical complete responders after chemoradioation for rectal cancerJ Clin Oncol20112946334010.1200/JCO.2011.37Open DOISearch in Google Scholar
Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 448 patients. J Am Coll Surg 2002; 194: 131-5.10.1016/S1072-7515(01)01159-0HiotisSPWeberSMCohenAMMinskyBDPatyPBGuillemJGAssessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 448 patientsJ Am Coll Surg20021941315Open DOISearch in Google Scholar
Chang KH, Smith MJ, McAnena OJ, Aprjanto AS, Dowdall JF. Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision. Int J Colorectal Dis 2012; 27: 1275-83. 10.1007/s00384-012-1440-822395659ChangKHSmithMJMcAnenaOJAprjantoASDowdallJF.Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excisionInt J Colorectal Dis20122712758310.1007/s00384-012-1440-8Open DOISearch in Google Scholar
Loos M, Quentmeier P, Schuster T, Nitsche U, Gertler R, Keerl A, et al. Effect of preoperative radio(chemo)therapy on long term functional outcome in rectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 2013; 20: 1816-28. 10.1245/s10434-012-2827-z23269466LoosMQuentmeierPSchusterTNitscheUGertlerRKeerlAEffect of preoperative radio(chemo)therapy on long term functional outcome in rectal cancer patients: a systematic review and meta-analysisAnn Surg Oncol20132018162810.1245/s10434-012-2827-zOpen DOISearch in Google Scholar
